Pulmovant
Healthcare & Life Sci
Company overview
Pulmovant is a company that develops therapies for pulmonary diseases. Its lead candidate is mosliciguat, an sGC activator the company describes as having the potential to be first-in-class, with a differentiated mechanism of activation. Pulmovant is based in Waltham, Massachusetts, at 303 Wyman Street. Pulmovant is an H-1B sponsor.
- Industry
- Healthcare & Life Sci
- Headquarters
- Waltham, United States